201 related articles for article (PubMed ID: 26453210)
1. Formation and Characterization of α-Synuclein Oligomers.
Paslawski W; Lorenzen N; Otzen DE
Methods Mol Biol; 2016; 1345():133-50. PubMed ID: 26453210
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence Methods for Unraveling Oligomeric Amyloid Intermediates.
Zijlstra N; Schilderink N; Subramaniam V
Methods Mol Biol; 2016; 1345():151-69. PubMed ID: 26453211
[TBL] [Abstract][Full Text] [Related]
3. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
[TBL] [Abstract][Full Text] [Related]
4. High stability and cooperative unfolding of α-synuclein oligomers.
Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
[TBL] [Abstract][Full Text] [Related]
5. Co-existence of two different α-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry.
Paslawski W; Mysling S; Thomsen K; Jørgensen TJ; Otzen DE
Angew Chem Int Ed Engl; 2014 Jul; 53(29):7560-3. PubMed ID: 24740651
[TBL] [Abstract][Full Text] [Related]
6. Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutants.
Tosatto L; Horrocks MH; Dear AJ; Knowles TP; Dalla Serra M; Cremades N; Dobson CM; Klenerman D
Sci Rep; 2015 Nov; 5():16696. PubMed ID: 26582456
[TBL] [Abstract][Full Text] [Related]
7. A glimpse into the structural properties of α-synuclein oligomers.
Santos J; Pallarès I; Ventura S
Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
Murata T; Tochio N; Utsunomiya-Tate N
Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
[TBL] [Abstract][Full Text] [Related]
9. Structural characteristics and membrane interactions of tandem α-synuclein oligomers.
Dong C; Hoffmann M; Li X; Wang M; Garen CR; Petersen NO; Woodside MT
Sci Rep; 2018 Apr; 8(1):6755. PubMed ID: 29712958
[TBL] [Abstract][Full Text] [Related]
10. How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein.
Andersen CB; Yoshimura Y; Nielsen J; Otzen DE; Mulder FAA
J Biol Chem; 2021; 296():100788. PubMed ID: 34019875
[TBL] [Abstract][Full Text] [Related]
11. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
[TBL] [Abstract][Full Text] [Related]
12. Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation.
Giehm L; Svergun DI; Otzen DE; Vestergaard B
Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3246-51. PubMed ID: 21300904
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry.
Mysling S; Betzer C; Jensen PH; Jorgensen TJ
Biochemistry; 2013 Dec; 52(51):9097-103. PubMed ID: 24191706
[TBL] [Abstract][Full Text] [Related]
14. Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
Andersen C; Grønnemose AL; Pedersen JN; Nowak JS; Christiansen G; Nielsen J; Mulder FAA; Otzen DE; Jørgensen TJD
Biochemistry; 2021 Nov; 60(47):3644-3658. PubMed ID: 34730940
[TBL] [Abstract][Full Text] [Related]
15. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
16. Oligomers of α-synuclein: picking the culprit in the line-up.
Lorenzen N; Otzen DE
Essays Biochem; 2014; 56():137-48. PubMed ID: 25131592
[TBL] [Abstract][Full Text] [Related]
17. Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.
Kurnik M; Sahin C; Andersen CB; Lorenzen N; Giehm L; Mohammad-Beigi H; Jessen CM; Pedersen JS; Christiansen G; Petersen SV; Staal R; Krishnamurthy G; Pitts K; Reinhart PH; Mulder FAA; Mente S; Hirst WD; Otzen DE
Cell Chem Biol; 2018 Nov; 25(11):1389-1402.e9. PubMed ID: 30197194
[TBL] [Abstract][Full Text] [Related]
18. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
[TBL] [Abstract][Full Text] [Related]
19. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.
Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D
Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735
[TBL] [Abstract][Full Text] [Related]
20. Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.
Betzer C; Movius AJ; Shi M; Gai WP; Zhang J; Jensen PH
PLoS One; 2015; 10(2):e0116473. PubMed ID: 25659148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
